Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss
- 1 May 2017
- journal article
- Published by Elsevier in NeuroToxicology
- Vol. 60, 99-106
Abstract
No abstract availableKeywords
Funding Information
- NIH (R01ES021800)
- Michael J Fox Foundation for Parkinson's Disease Research
- Glenn and Karen Leppo
- Richard Nicely
- Allan and Janice Woll Parkinson's Research Funds
This publication has 42 references indexed in Scilit:
- MPTP neurotoxicity is highly concordant between the sexes among BXD recombinant inbred mouse strainsNeuroToxicology, 2016
- Unexpected toxicity of very low dose MPTP in mice: A clue to the etiology of Parkinson's disease?Synapse, 2015
- Hippocampal ER Stress and Learning Deficits Following Repeated Pyrethroid ExposureToxicological Sciences, 2014
- Genetic-based, differential susceptibility to paraquat neurotoxicity in miceNeurotoxicology and Teratology, 2011
- Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanismsThe Lancet Neurology, 2009
- Parkinson Phenotype in Aged PINK1-Deficient Mice Is Accompanied by Progressive Mitochondrial Dysfunction in Absence of NeurodegenerationPLOS ONE, 2009
- DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidaseProceedings of the National Academy of Sciences, 2007
- Mouse models of α-synucleinopathy and Lewy pathologyExperimental Gerontology, 2000
- Characterization of the origins of astrocyte response to injury using the dopaminergic neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineBrain Research, 1990
- Strain differences in systematic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrierLife Sciences, 1988